Anti-Hyperglycemic Activity of Moxonidine: Metabolic and Molecular Effects in Obese Spontaneously Hypertensive Rats
- 1 January 1998
- journal article
- Published by Taylor & Francis in Blood Pressure
- Vol. 7 (sup3) , 32-39
- https://doi.org/10.1080/080370598438465
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDMDiabetes, 1997
- Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky ratNature Genetics, 1996
- I1‐Imidazoline ReceptorsAnnals of the New York Academy of Sciences, 1995
- Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.Journal of Clinical Investigation, 1995
- Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1Nature, 1994
- Insulin Action, Diabetogenes, and the Cause of Type II DiabetesDiabetes, 1994
- Hypertension in Obesity and NIDDM: Role of Insulin and Sympathetic Nervous SystemDiabetes Care, 1991
- A 48-hour Lipid Infusion in the Rat Time-Dependently Inhibits Glucose-Induced Insulin Secretion and B Cell Oxidation Through a Process Likely Coupled to Fatty Acid Oxidation*Endocrinology, 1990
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988
- Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.Journal of Clinical Investigation, 1983